CLOS
XBI icon

Compagnie Lombard Odier SCmA’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,240
Closed -$103K – 471
2025
Q2 		$103K Hold
1,240
– – ﹤0.01% 285
2025
Q1 		$101K Sell
1,240
-2,400
-66% -$215K ﹤0.01% 304
2024
Q4 		$328K Buy
3,640
+1,240
+52% +$120K ﹤0.01% 207
2024
Q3 		$237K Sell
2,400
-575
-19% -$56.5K ﹤0.01% 229
2024
Q2 		$276K Hold
2,975
– – ﹤0.01% 215
2024
Q1 		$282K Hold
2,975
– – 0.01% 227
2023
Q4 		$266K Hold
2,975
– – ﹤0.01% 257
2023
Q3 		$217K Buy
2,975
+2,400
+417% +$192K 0.01% 257
2023
Q2 		$47.8K Buy
+575
New +$48.1K ﹤0.01% 417
2022
Q3 		– Sell
-2,728
Closed -$230K – 697
2022
Q2 		$202K Buy
+2,728
New +$205K 0.01% 292
2018
Q4 		– Sell
-300
Closed -$29K – 612
2018
Q3 		$29K Sell
300
-1,230
-80% -$119K ﹤0.01% 469
2018
Q2 		$146K Sell
1,530
-20
-1% -$1.84K 0.01% 319
2018
Q1 		$136K Sell
1,550
-250
-14% -$22.8K 0.01% 347
2017
Q4 		$152K Sell
1,800
-13,240
-88% -$1.11M 0.01% 345
2017
Q3 		$1.3M Sell
15,040
-4,530
-23% -$363K 0.05% 197
2017
Q2 		$1.51M Buy
19,570
+300
+2% +$21.3K 0.05% 194
2017
Q1 		$1.34M Sell
19,270
-6,300
-25% -$423K 0.05% 203
2016
Q4 		$1.51M Buy
25,570
+1,000
+4% +$61.7K 0.04% 214
2016
Q3 		$1.63M Buy
24,570
+14,770
+151% +$914K 0.05% 209
2016
Q2 		$530K Buy
9,800
+9,500
+3,167% +$521K 0.02% 333
2016
Q1 		$15K Hold
300
– – ﹤0.01% 851
2015
Q4 		$21K Hold
300
– – ﹤0.01% 799
2015
Q3 		$19K Hold
300
– – ﹤0.01% 706
2015
Q2 		$25K Hold
300
– – ﹤0.01% 695
2015
Q1 		$23K Buy
+300
New +$21K ﹤0.01% 851

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Compagnie Lombard Odier SCmA's XBI Position: Q3 2025 in Review

Compagnie Lombard Odier SCmA sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 1,240 shares — an estimated $103K sold.

Compagnie Lombard Odier SCmA first reported a position in XBI in Q1 2015 and held it in 25 quarters. The position peaked at $1.63M in Q3 2016. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Compagnie Lombard Odier SCmA reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1,240 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $103K.
  • Compagnie Lombard Odier SCmA first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 25 quarters.
  • Compagnie Lombard Odier SCmA's State Street SPDR S&P Biotech ETF position peaked at $1.63M in Q3 2016.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2025, filed 6 Nov 2025.